Day: November 15, 2023

RYE, N.Y., Nov. 15, 2023 (GLOBE NEWSWIRE) — Gabelli Funds, LLC will host the 5th Annual Healthcare Symposium with Columbia Business School at the Paley Center on Friday, November 17th, 2023. This half-day symposium will bring together leading healthcare executives and physicians to discuss current and future trends in the industry. Topics include the evolution of primary care practices, advances in regenerative medicine, and the future of Medicare Advantage.Agenda    8:15am   Breakfast Welcoming      8:45   Remarks     9:00   Panel 1: Reimagining Primary Care, Jeff Jonas    Tim Cook, Vivek Garg, Emily Maxson10:00   Break     10:10   Panel 2: Trends in Regenerative Medicine, Sara Wojda    Stuart Hart, Sonya Herrick, Scott Rodeo, Nina Tandon11:10   Break     11:20   Panel 3: The Future of...

The second annual ranking includes 250 advisory firms with cumulative assets of more than $1.1 trillion MORRISTOWN, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) — Beacon Trust, a full-service wealth management firm, announced it has been named on the Forbes ranking of America’s Top RIA Firms, developed by SHOOK Research. The list of top registered investment advisory (RIA) firms is based on an independent national survey conducted by SHOOK Research, including qualitative and quantitative factors, compliance records, revenue produced, and telephone and in-person interviews. “I am thrilled that the Forbes ranking of America’s Top RIA Firms has recognized Beacon Trust, which is truly a testament to our commitment to excellence in wealth management,” said Valerie Murray, president of Beacon Trust and chief wealth management...

VANCOUVER, Wash. and NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, NY. Absci management is scheduled to present on Wednesday, November 29th at 10:50 a.m. Eastern Time (7:50 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website at: investors.absci.com. About Absci Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing...

WINNIPEG, Manitoba, Nov. 15, 2023 (GLOBE NEWSWIRE) — (TSX: NWC): The North West Company Inc. (the “Company” or “North West”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted notice of the Company’s intention to make a normal course issuer bid (“NCIB”) for a portion of its common voting shares and variable voting shares (the “Shares”) as appropriate opportunities arise from time to time. The board of directors of the Company believes that the purchase by the Company of a portion of its outstanding Shares may from time to time be an appropriate use of available resources and in the best interests of the Company. Pursuant to the NCIB notice filed with the TSX, the Company may acquire up to a maximum of 4,733,380 of its Shares, or approximately 10% of its public float as of the date of November 9, 2023, for...

VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that its patent application for BETR-001 and LSD derivatives titled “LSD derivatives, synthesis & method for treatment of diseases and disorders” has been published by the United States Patent and Trademark Office (“USPTO”) under publication number US-2023/0357243-A1 and available for access on USPTO’s databases. BetterLife is presently developing one of these derivatives: a 2-bromo derivative of LSD (BETR-001) that is non-hallucinogenic and, in preclinical animal models, has been shown to be a potent neuroplastogen and have...

WESTPORT, Conn., Nov. 15, 2023 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today the completion of the Company’s previously announced sale of its majority owned subsidiary, Wheelhouse Holdings, Inc. (“Marucci”), the parent company of Marucci Sports, LLC, to Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX”), a designer and manufacturer of performance-defining ride dynamics products primarily for a wide range of bicycles, on-road and off-road vehicles. The sale price was based on an enterprise value of $572 million, subject to certain working capital and other adjustments. After these adjustments, as well as for an allocation to Marucci’s non-controlling shareholders and the payment of transaction expenses, CODI received approximately $485 million...

EMERYVILLE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT, 4DMT, or the Company), a genetic medicines company with three novel, highly targeted next generation AAV vectors currently in human clinical studies, announced today that management will participate in a fireside chat at an upcoming investor conference in November. Members of the management team will also be available for one-on-one meetings in connection with this meeting. 6th Annual Evercore ISI HealthCONx ConferencePresentation Date: Tuesday, November 28, 2023Presentation Time: 1:45 p.m. ETWebcast Link: WebcastArchived copies of the webcasts will be available for up to one year by visiting the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events. About 4DMT  4DMT is a clinical-stage...

BEIJING, Nov. 15, 2023 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of next-generation mobile internet infrastructure and platform services, today announced that its multimodal artificial intelligence content creation platform CHEERS Telepathy has officially launched its app and WeChat mini program after completing all relevant regulatory filings and is now fully compliant. Now, users can immerse themselves in the boundless possibilities of CHEERS Telepathy across three platforms: the app, WeChat mini program, and PC. The core capabilities of CHEERS Telepathy range from advanced models and algorithms to seamless multimodal integration that help converge logic and understanding, weave memories into extraordinary creations. CHEERS Telepathy facilitates release of creativity...

BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Howard Mayer, M.D. to the PepGen Board of Directors, effective November 15, 2023. “We are pleased to welcome Dr. Mayer to the PepGen Board,” said James McArthur, Ph.D., President and CEO of PepGen. “His extensive clinical development and regulatory experience across a variety of therapeutic areas, including multiple global regulatory filings and approvals in rare diseases, will be invaluable to PepGen as we create the new generation of genetic therapies for devastating neuromuscular diseases.” Dr. Mayer was most recently Executive Vice...